2006
DOI: 10.1016/s1550-8579(06)80202-0
|View full text |Cite
|
Sign up to set email alerts
|

Gender-specific care of the patient with diabetes: Review and recommendations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
152
2
13

Year Published

2007
2007
2019
2019

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 208 publications
(178 citation statements)
references
References 168 publications
11
152
2
13
Order By: Relevance
“…Previous studies have found worse BP control, higher SBP [22] and higher LDLcholesterol in women patients [26]. It has therefore been suggested that women might be receiving lower-quality treatment [27], possibly contributing to their excess cardiovascular morbidity and mortality rates [3,28]. However, we detected only minor, clinically irrelevant changes in cardiovascular risk factors and no differences in diabetes-related complications between men and women.…”
Section: Discussioncontrasting
confidence: 51%
“…Previous studies have found worse BP control, higher SBP [22] and higher LDLcholesterol in women patients [26]. It has therefore been suggested that women might be receiving lower-quality treatment [27], possibly contributing to their excess cardiovascular morbidity and mortality rates [3,28]. However, we detected only minor, clinically irrelevant changes in cardiovascular risk factors and no differences in diabetes-related complications between men and women.…”
Section: Discussioncontrasting
confidence: 51%
“…Female sex during adolescence has been shown to exert a positive influence on insulin sensitivity, lipids and blood pressure (Moran et al 2008), which is in line with the notion that premenopausal women have a lower risk of developing the metabolic syndrome compared with age-matched men (Isomaa et al 2001, Legato et al 2006, Regitz-Zagrosek et al 2007. No single risk factor or combination of factors has yet been shown to fully explain this, but the fact that risk protection disappears after menopause strongly suggests that female hormones play a protective role.…”
Section: Introductionsupporting
confidence: 56%
“…Since 1994, the NIH has also required analyses of trial outcomes by sex. Nevertheless, even if scientific journals are more aware of sex/gender nowadays, there are still many recommendations about treatments and drugs that are based on studies where the majority of participants were men [33][34][35][36][37]. It is equally common that no sex-based analyses are performed even though both men and women are enrolled, or that too few women (or men) were included to allow for sex-based analyses.…”
Section: Gender Blindness In Researchmentioning
confidence: 99%